|
Hi,
I was reading Oct issue of Redbook and they have a continuing story on this young lady, Gina and her battle with b.c. Last year featured her tx with Neoadjuvant ACT then lumpectomy and rads. I recently read in the article that she is Her2 + so they called her in to have a year of Herceptin q.3 weeks. Does'nt this sound strange to anyone. I thought that Sloane-Kettering was one of the best and most forward thinking institutions around. I can't imagine why this 37 year old wasn't offered the poss. of a clinical trial w. Herceptin. I know I am kind of upset myself that my mom wasn't in the Taxol + Herceptin arm, but I am still worried docs are way behind on tx.
Anne
|